{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:19:44Z","timestamp":1786735184506,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ccm.2023.08.007","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T07:39:38Z","timestamp":1693553978000},"page":"185-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sarcoidosis-Associated Pulmonary Hypertension"],"prefix":"10.1016","volume":"45","author":[{"given":"Laurent","family":"Savale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dorfm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ath\u00e9na\u00efs","family":"Boucly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Ja\u00efs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lacoste-Palasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Jevnikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Seferian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"163","key":"10.1016\/j.ccm.2023.08.007_bib1","doi-asserted-by":"crossref","first-page":"210165","DOI":"10.1183\/16000617.0165-2021","article-title":"WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension","volume":"31","author":"Savale","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ccm.2023.08.007_bib2","first-page":"2200879","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"30","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.007_bib3","doi-asserted-by":"crossref","first-page":"1700465","DOI":"10.1183\/13993003.00465-2017","article-title":"Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.007_bib4","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1038\/s41598-019-40030-w","article-title":"Clinical features and outcomes of patients with sarcoidosis-associated pulmonary hypertension","volume":"9","author":"Parikh","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.007_bib5","doi-asserted-by":"crossref","first-page":"1901747","DOI":"10.1183\/13993003.01747-2019","article-title":"Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry","volume":"55","author":"Shlobin","year":"2020","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.007_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.05.00083404","article-title":"Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics","volume":"25","author":"Shorr","year":"2005","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.007_bib7","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1378\/chest.129.5.1246","article-title":"Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis","volume":"129","author":"Handa","year":"2006","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.007_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1183\/09031936.00175907","article-title":"Clinical predictors of pulmonary hypertension in sarcoidosis","volume":"32","author":"Bourbonnais","year":"2008","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.007_bib9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1378\/chest.128.3.1483","article-title":"Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension","volume":"128","author":"Sulica","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.007_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.2005.042838","article-title":"Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis","volume":"61","author":"Nunes","year":"2006","journal-title":"Thorax"},{"issue":"44","key":"10.1016\/j.ccm.2023.08.007_bib11","doi-asserted-by":"crossref","first-page":"e1800","DOI":"10.1097\/MD.0000000000001800","article-title":"Pulmonary hypertension complicating fibrosing mediastinitis","volume":"94","author":"Seferian","year":"2015","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.007_bib12","first-page":"50","article-title":"Cardiac sarcoidosis-state of the art review","volume":"6","author":"Hulten","year":"2016","journal-title":"Cardiovasc Diagn Ther"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.007_bib13","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation","volume":"138","author":"Baughman","year":"2010","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.007_bib14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1378\/chest.11-2514","article-title":"Increased number of pulmonary embolisms in sarcoidosis patients","volume":"141","author":"Vorselaars","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.007_bib15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1378\/chest.11-0324","article-title":"Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007","volume":"140","author":"Swigris","year":"2011","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.007_bib16","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.5664\/jcsm.10140","article-title":"The prevalence of obstructive sleep apnea in sarcoidosis and its impact on sleepiness, fatigue, and sleep-associated quality of life: a cross-sectional study with matched controls (the OSASA study)","volume":"18","author":"Roeder","year":"2022","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.007_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/1817-1737.62471","article-title":"Sarcoidosis-associated pulmonary hypertension: clinical features and outcomes in Arab patients","volume":"5","author":"Alhamad","year":"2010","journal-title":"Ann Thorac Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.007_bib18","doi-asserted-by":"crossref","first-page":"1900897","DOI":"10.1183\/13993003.00897-2019","article-title":"Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study","volume":"54","author":"Huitema","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.007_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.007_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2023.08.007_bib21","doi-asserted-by":"crossref","first-page":"105997","DOI":"10.1016\/j.rmed.2020.105997","article-title":"Predictors of mortality in fibrosing pulmonary sarcoidosis","volume":"169","author":"Jeny","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.007_bib22","doi-asserted-by":"crossref","first-page":"106801","DOI":"10.1016\/j.rmed.2022.106801","article-title":"The six-minute walk test in sarcoidosis associated pulmonary hypertension: results from an international registry","volume":"196","author":"Gupta","year":"2022","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.ccm.2023.08.007_bib23","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.007_bib24","first-page":"e2021032","article-title":"Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study","volume":"38","author":"Huitema","year":"2022","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.007_bib25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1378\/chest.13-1766","article-title":"Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial","volume":"145","author":"Baughman","year":"2014","journal-title":"Chest"},{"issue":"21","key":"10.1016\/j.ccm.2023.08.007_bib26","first-page":"03613","article-title":"Riociguat for sarcoidosis associated pulmonary hypertension: results of a one year double blind, placebo controlled trial","volume":"S0012-3692","author":"Baughman","year":"2021","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.007_bib27","first-page":"110","article-title":"Inhaled iloprost for sarcoidosis associated pulmonary hypertension","volume":"26","author":"Baughman","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.007_bib28","first-page":"139","article-title":"Ambrisentan for sarcoidosis associated pulmonary hypertension","volume":"28","author":"Judson","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.007_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1086\/688775","article-title":"Tadalafil therapy for sarcoidosis-associated pulmonary hypertension","volume":"6","author":"Ford","year":"2016","journal-title":"Pulm Circ"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.007_bib30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1378\/chest.08-1881","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience","volume":"135","author":"Barnett","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.007_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-2600(16)30438-6","article-title":"Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study","volume":"5","author":"Montani","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.007_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2023.08.007_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.rmed.2018.04.015","article-title":"Clinical features of sarcoidosis associated pulmonary hypertension: results of a multi-national registry","volume":"139","author":"Baughman","year":"2018","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.007_bib34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/crj.12435","article-title":"Interventional therapy in sarcoidosis-associated pulmonary arterial stenosis and pulmonary hypertension","volume":"11","author":"Liu","year":"2017","journal-title":"Clin Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.007_bib35","first-page":"281","article-title":"Pulmonary stenting for the treatment of sarcoid induced pulmonary vascular stenosis","volume":"33","author":"Condado","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.007_bib36","doi-asserted-by":"crossref","first-page":"100616","DOI":"10.1016\/j.cpcardiol.2020.100616","article-title":"Characteristics and outcomes of pulmonary angioplasty with or without stenting for sarcoidosis-associated pulmonary hypertension: systematic review and individual participant data meta-analysis","volume":"46","author":"daSilva-deAbreu","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.ccm.2023.08.007_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40248-016-0075-y","article-title":"Hemothorax following lung transplantation: incidence, risk factors, and effect on morbidity and mortality","volume":"11","author":"Hong","year":"2016","journal-title":"Multidiscip Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.007_bib38","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0037-1602383","article-title":"Solid organ transplantation in sarcoidosis","volume":"38","author":"Yserbyt","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.007_bib39","doi-asserted-by":"crossref","first-page":"2003358","DOI":"10.1183\/13993003.03358-2020","article-title":"Lung transplantation for sarcoidosis: outcome and prognostic factors","volume":"58","author":"Le Pavec","year":"2021","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.007_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/thoraxjnl-2015-207497","article-title":"Lung transplantation for pulmonary sarcoidosis. Twenty-five years of experience in the USA","volume":"71","author":"Taimeh","year":"2016","journal-title":"Thorax"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252312300076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252312300076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:16:37Z","timestamp":1759454197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027252312300076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S027252312300076X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2023.08.007","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcoidosis-Associated Pulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2023.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}